Trial intelligence / Profile preview

Phase III randomized blinded study of three Priorix-Tetra production lots in toddlers

2004-005263-19Phase 3Completed

Sponsor
GSK
Start
Feb 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of GSK208136 in measles, mumps, rubella, chickenpox, sponsored by GSK. Started Feb 2005; status: completed.

02

Drugs

GSK208136
03

Conditions

measlesmumpsrubellachickenpox

Beyond the preview

Go deeper on 2004-005263-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-005263-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call